Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversibility of cerebrovascular endothelial dysfunction in diabetes: the role of allopurinol
2005-001670-27Phase 4Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in type 2 diabetes mellitus (T2DM), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Change in internal carotid artery (ICA) flow induced by L-NMMA infusion. Started Oct 2005; status: terminated.
02
Drugs
allopurinol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-001670-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001670-27.